CS logo
small CS logo
CHU (Hôpital Calmette) - Pneumologie

Lille, France
General hospital in Lille
Bd du Professeur Jules Leclercq, 59000 Lille

About CHU (Hôpital Calmette) - Pneumologie


"Hôpital public à Lille"
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at CHU (Hôpital Calmette) - Pneumologie


During the past decade, CHU (Hôpital Calmette) - Pneumologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "CHU (Hôpital Calmette) - Pneumologie" #1 collaborator was "Groupe Francais De Pneumo-Cancerologie" with 2 trials as a collaborator and "University Hospital, Caen" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at CHU (Hôpital Calmette) - Pneumologie


According to Clinical.Site data, the most researched conditions in "CHU (Hôpital Calmette) - Pneumologie" are "Idiopathic Pulmonary Fibrosis" (3 trials), "ALK Gene Mutation" (1 trials), "Advanced Non Small Cell Lung Cancer" (1 trials), "Asthma" (1 trials) and "BRAF Gene Mutation" (1 trials). Many other conditions were trialed in "CHU (Hôpital Calmette) - Pneumologie" in a lesser frequency.

Clinical Trials Intervention Types at CHU (Hôpital Calmette) - Pneumologie


Most popular intervention types in "CHU (Hôpital Calmette) - Pneumologie" are "Drug" (9 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab" (2 trials), "Docetaxel" (2 trials), "Erlotinib" (2 trials), "Lebrikizumab" (2 trials) and "Pemetrexed" (2 trials). Other intervention names were less common.

Clinical Trials Genders at CHU (Hôpital Calmette) - Pneumologie


The vast majority of trials in "CHU (Hôpital Calmette) - Pneumologie" are 10 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at CHU (Hôpital Calmette) - Pneumologie


Currently, there are NaN active trials in "CHU (Hôpital Calmette) - Pneumologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in CHU (Hôpital Calmette) - Pneumologie, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in CHU (Hôpital Calmette) - Pneumologie, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".